Tag Archives: NASDAQ:XOMA

Xoma (XOMA) Gets a Buy Rating from Wedbush

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Xoma (XOMA – Research Report), with a price target of $29.00. The company’s shares closed last Tuesday at $23.85. According to TipRanks.com, Moussatos is ranked 0

Analysts Offer Insights on Healthcare Companies: Xoma (NASDAQ: XOMA) and Amgen (NASDAQ: AMGN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Xoma (XOMA – Research Report) and Amgen (AMGN – Research Report). Xoma (XOMA) In a report released today, Joseph Pantginis from H.C. Wainwright

The CEO of Xoma (NASDAQ: XOMA) is Buying Shares

Yesterday, the CEO of Xoma (XOMA – Research Report), James Neal, bought shares of XOMA for $25.96K. Following James Neal’s last XOMA Buy transaction on December 21, 2018, the stock climbed by 12.5%. This recent transaction increases James Neal’s holding

Wedbush Keeps Their Buy Rating on Xoma Corp (XOMA)

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Xoma Corp (XOMA – Research Report), with a price target of $25. The company’s shares closed yesterday at $15.99. According to TipRanks.com, Moussatos ‘ ranking currently

Xoma Corp (XOMA) Receives a Buy from Wedbush

Wedbush analyst Liana Moussatos reiterated a Buy rating on Xoma Corp (XOMA – Research Report) today and set a price target of $25. The company’s shares opened today at $18.26. According to TipRanks.com, Moussatos is currently ranked with no stars

A Director at Xoma Corp (NASDAQ: XOMA) is Selling Shares

Today, a Director at Xoma Corp (XOMA – Research Report), Denman Van-Ness, sold shares of XOMA for $1,911. Following Denman Van-Ness’ last XOMA Sell transaction on December 21, 2018, the stock climbed by 3.3%. See today’s analyst top recommended stocks